Mature adrenomedullin for therapy stratification of corticosteroids in critically ill patients
AssigneeSphingotec GmbH
InventorsDeborah BERGMANN, Florian UHLE
Life of this patent
Estimating the term…
Loading patent…
AssigneeSphingotec GmbH
InventorsDeborah BERGMANN, Florian UHLE
Estimating the term…
A method of selecting critically ill patients for treatment with corticosteroids, by determining the level of ADM-NH2 or fragment thereof in a sample of bodily fluid of the patient, comparing the level of ADM-NH2 or fragment thereof to a pre-determined threshold or to a previously measured level of ADM-NH2 or fragment thereof, and at a value above the threshold appointing a therapy with corticosteroids. A method for corticosteroid therapy guidance and/or stratification in critically ill patients by providing a sample of bodily fluid of the patient, and determining the level of ADM-NH2 or fragment thereof in the sample, and comparing the level of ADM-NH2 or fragment thereof to a pre-determined threshold or to a previously measured level of ADM-NH2 or fragment thereof, wherein the level of ADM-NH2 or fragments thereof is indicative of whether an initiation of a corticosteroid therapy is required.
A method comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A sample comprising:
Dependencies are inferred from the claim text.